Evaluation of the hemoglobin A1c-analyzer TOSOH HLC-723 G7

Clinical Laboratory

Volumn 49, Issue 5-6, 2003, Pages 243-250

  Gremmels, Heinz Detlef ^a   Richter, Anja ^a   Watzke, Ivonne ^a  

^a Medizinisch Diagnostische Institute   (Germany)

Author keywords

Diabetes; Glycated haemoglobin; HbA1c; HPLC; L A1c

Indexed keywords

BILIRUBIN; HEMOGLOBIN A1C; TRIACYLGLYCEROL; UREA;

ARTICLE; AUTOANALYZER; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; CHROMATOGRAPHY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; REPRODUCIBILITY; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL;

CALIBRATION; CLINICAL MEDICINE; HEMOGLOBINOMETRY; HEMOGLOBINS; HUMANS; LABORATORIES; REPRODUCIBILITY OF RESULTS;

EID: 0038749533     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Trivelli LA, Ranney HM, Lan H-T. Hemoglobin components in patients with diabetes mellitus. New Eng J Med 1971; 284: 353-357.
2. Abraham EC, Huff TA, Cope ND, Wilson JB, Bransome ED, Huisman THJ. Determination of the glycosylated hemoglobins (HbA1) with a new microcolumn procedure. Diabetes 1978; 27: 931-937.
3. Holbrook I. Measurement of HbA1c by high-performance liquid chromatography in patients with renal failure. Ann Clin Biochem 1999; 36: 238-239.
4. Thoma J, Stirn F, Kutter D. Influence of urea on HbA1c determinations by Menarini HA-8140 and on the difference between immunoturbidimetric and HPLC-HbA1c results. Clin Lab 2000; 46: 261-268.
5. Chachon A, Randoux C, Millart H, Charnard J, Gillery P. Influence of in vivo hemoglobin carbamylation on HbA1c measurements by various methods. Clin Chem Lab Med 2000; 38 (4): 321-326.
6. Fraser, CG, Hyltoft Petersen P, Larsen ML. Setting analytical goals for random analytical error in specific clinical monitoring situations. Clin Chem 1990; 36: 1625-1628.
7. Phillipou G, Phillips PJ. Intra-individual variation of glycohemoglobin: implications for interpretation and analytical goals. Clin Chem 1993; 39:2305-2308.
8. Kolatkar NS, Cembrowski GS, Callahan PL, Etzwiler DD. Intensive diabetes management requires very precise testing of glycohemoglobin (Letter). Clin Chem 1994; 8:1608-1609.
9. Chevenne D, Marle N, Chauffert M, Noel M, Ducrocq R, Trivin F. Evaluation of the TOSOH HLC-723GHb V A1c 2.2. Hemoglo-bin A1c Analyzer. Clin Biochem 1999; 32:487-490.
10. Gibb I, Parnham A, Fonfrede M, Lecock F. Multicenter evaluation of TOSOH glycohemoglobin analyzer. Clin Chem 1999;45: 1833-1841.
11. Stoot A, Casson IF, Higgins GJ. Glycated haemoglobin assays. Approaches to standardization of results. Diabet Med 2001; 18(4):274-279.
12. Weykamp, CW, Penders TJ, Siebelder CWM, Muskiet FAJ, van der Slik W. Interference of carbamylated and acetylated hemoglobins in assays of glycohemoglobin by HPLC, electrophoresis, affinity chromatography, and enzyme immunoassay. Clin Chem 1993; 39: 138-142.
13. Chevenne D, Fonfrede M, Ducrocq R, Chauffert M, Trivin F. Uremia and HbA1c measured by high-performance liquid chromatography (Letter). Diabetes Care 1998; 21: 463-464.
14. Anonymus. TOSOH automated glycohemoglobin analyzer HLC-723 GHb V. Technical report. TOSOH Corporation, 1997.
15. Mullins RE, Austin GE. Sensitivity of iso-electric focusing, ion exchange and affinity chromatography to labile glycated hemoglobin. Clin Chem 1986; 32: 1460-1463.
16. Bannon P, Jolly JG, Lessard F, Lepage R. Comparison of three methods for the elimination of the labile fraction of HbA1. Clin Biochem 1985; 18: 114-117.
17. Ellis G. Incomplete removal of labile fraction when measuring hemoglobin A1c with the Bio-Rad Variant analyzer (Letter). Clin Chem 1997; 43: 968-975.